Citation: Ty. Wu et Wr. Fleischmann, ENHANCED EFFICACY OF B16-ALPHA CELLS AS A TUMOR VACCINE IN MICE IS MEDIATED BY MACROPHAGES AND T-CELLS AND MAY INVOLVE BREAKING TOLERANCE, European cytokine network, 9(3), 1998, pp. 230-230
Citation: Ty. Wu et Wr. Fleischmann, EFFICACY OF B16 MELANOMA-CELLS EXPOSED IN-VITRO TO LONG-TERM IFN-ALPHA TREATMENT (B16-ALPHA CELLS) AS A TUMOR VACCINE IN MICE, Journal of interferon & cytokine research, 18(10), 1998, pp. 829-839
Authors:
FLEISCHMANN WR
MASOOR J
WU TY
FLEISCHMANN CM
Citation: Wr. Fleischmann et al., ORALLY-ADMINISTERED IFN-ALPHA ACTS ALONE AND IN SYNERGISTIC COMBINATION WITH INTRAPERITONEALLY ADMINISTERED IFN-GAMMA TO EXERT AN ANTITUMOREFFECT AGAINST B16 MELANOMA IN MICE, Journal of interferon & cytokine research, 18(1), 1998, pp. 17-20
Citation: Cm. Fleischmann et al., B16 MELANOMA-CELLS EXPOSED IN-VITRO TO LONG-TERM IFN-ALPHA TREATMENT (B16-ALPHA CELLS) AS ACTIVATORS OF TUMOR-IMMUNITY IN MICE, Journal of interferon & cytokine research, 17(1), 1997, pp. 37-43
Authors:
ARANY I
FLEISCHMANN CM
TYRING SK
FLEISCHMANN WR
Citation: I. Arany et al., LACK OF MDA-6 WAF1/CIP1-MEDIATED INHIBITION OF CYCLIN-DEPENDENT KINASES IN INTERFERON-ALPHA RESISTANT MURINE B16 MELANOMA-CELLS/, Cancer letters, 119(2), 1997, pp. 237-240
Authors:
ARANY I
FLEISCHMANN CM
TYRING SK
FLEISCHMANN WR
Citation: I. Arany et al., INTERFERON REGULATES EXPRESSION OF MDA-6 WAF1/CIP1 AND CYCLIN-DEPENDENT KINASES INDEPENDENTLY FROM P53 IN B16 MURINE MELANOMA-CELLS/, Biochemical and biophysical research communications, 233(3), 1997, pp. 678-680
Citation: Cm. Fleischmann et al., ENHANCED IN-VIVO SENSITIVITY OF IN-VITRO INTERFERON-TREATED B16 MELANOMA-CELLS TO CD8 CELLS AND ACTIVATED MACROPHAGES, Journal of interferon & cytokine research, 16(10), 1996, pp. 805-812
Citation: Cm. Fleischmann et Wr. Fleischmann, ENHANCED IN-VITRO MACROPHAGE CYTOTOXICITY AGAINST INTERFERON-TREATED B16 MELANOMA-CELLS, Journal of biological regulators and homeostatic agents, 9(4), 1995, pp. 139-145
Authors:
JEZERSEK B
NOVAKOVIC S
SERSA G
AUERSPERG M
FLEISCHMANN WR
Citation: B. Jezersek et al., INTERACTIONS OF INTERFERON AND VINBLASTINE ON EXPERIMENTAL TUMOR-MODEL MELANOMA-B-16 IN-VITRO, Anti-cancer drugs, 5(1), 1994, pp. 53-56
Citation: Wr. Fleischmann et Cm. Fleischmann, ENHANCEMENT OF MUIFN-GAMMA ANTITUMOR EFFECTS BY HYPERTHERMIA - SEQUENCE DEPENDENCE AND TIME-DEPENDENCE OF HYPERTHERMIA, Journal of biological regulators and homeostatic agents, 8(4), 1994, pp. 101-107
Citation: Cm. Fleischmann et al., ENHANCED IN-VIVO SENSITIVITY TO INTERFERON WITH IN-VITRO RESISTANT B16 TUMOR-CELLS IN MICE, Cancer immunology and immunotherapy, 39(3), 1994, pp. 148-154
Citation: S. Koren et Wr. Fleischmann, MODULATION OF PERIPHERAL LEUKOCYTE COUNTS AND BONE-MARROW FUNCTION INMICE BY ORAL-ADMINISTRATION OF INTERLEUKIN-2, Journal of interferon research, 14(6), 1994, pp. 343-347
Citation: S. Koren et al., CIRCADIAN DEPENDENCE OF INTERFERON ANTITUMOR-ACTIVITY IN MICE, Journal of the National Cancer Institute, 85(23), 1993, pp. 1927-1932
Citation: Cm. Fleischmann et al., PREVENTION OF RESISTANCE TO IFN-ALPHA ANTIPROLIFERATIVE ACTIVITY - CHARACTERIZATION OF THE EFFECT OF IFN-GAMMA AND SUBSTITUTION FOR IFN-GAMMA BY TUMOR-NECROSIS-FACTOR, Journal of biological regulators and homeostatic agents, 7(2), 1993, pp. 50-57
Citation: S. Koren et Wr. Fleischmann, CIRCADIAN VARIATIONS IN MYELOSUPPRESSIVE ACTIVITY OF INTERFERON-ALPHAIN MICE - IDENTIFICATION OF AN OPTIMAL TREATMENT TIME ASSOCIATED WITHREDUCED MYELOSUPPRESSIVE ACTIVITY, Experimental hematology, 21(4), 1993, pp. 552-559
Citation: S. Koren et Wr. Fleischmann, OPTIMAL CIRCADIAN TIMING REDUCES THE MYELOSUPPRESSIVE ACTIVITY OF RECOMBINANT MURINE INTERFERON-GAMMA ADMINISTERED TO MICE, Journal of interferon research, 13(3), 1993, pp. 187-195
Citation: S. Koren et Wr. Fleischmann, ORALLY-ADMINISTERED INTERFERONS SUPPRESS BONE-MARROW FUNCTION, Proceedings of the Society for Experimental Biology and Medicine, 204(2), 1993, pp. 155-164